News
08-02-2012, 02:12 AM
A study co-authored by a Loyola researcher and published in the New England Journal of Medicine is offering new hope to women with advanced breast cancer. The study found that combing two drugs that normally are each given as single agents significantly extended the lives of women with metastatic breast cancer...
More... (http://www.medicalnewstoday.com/releases/248530.php)
More... (http://www.medicalnewstoday.com/releases/248530.php)